LI Hong tao *, LIU Hong bin, ZHAO Qing chuan, et al. Prospect of cetuximab in the treatment of colorectal cancer[J]. Chinese Journal of Digestive Surgery, 2013, 12(7): 556-560. DOI: 10.3760/cma.j.issn.1673-9752.2013.07.022
Citation: LI Hong tao *, LIU Hong bin, ZHAO Qing chuan, et al. Prospect of cetuximab in the treatment of colorectal cancer[J]. Chinese Journal of Digestive Surgery, 2013, 12(7): 556-560. DOI: 10.3760/cma.j.issn.1673-9752.2013.07.022

Prospect of cetuximab in the treatment of colorectal cancer

  • Colorectal cancer is one of the most common malignant tumors. With the improvement of living condition and peopleslife span, the incidence rate of colorectal cancer has been ascending year by year. In developed countries and developed district of China, colorectal cancer has become the second common malignant tumor. More than one million people were diagnosed as with colorectal cancer, and 500,000 of them died yearly. Colorectal cancer is one of the most common reasons of the death of cancer patients. With the development of molecular targeted agents research, the therapeutic effects for colorectal cancer patients have been improved, and the current status and prospect of targeted therapy for colorectal cancer patients were introduced in this review.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return